European Commission approves Aubagio® (teriflunomide) as the first oral MS therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis
European Commission approves Aubagio® (teriflunomide) as the first oral MS therapy…
Lithosphere Reduces Blockchain Fragmentation Through MultX Interoperability Engine
Solutionz Group Announces Launch of Growth Multiplier Category Framework and Establishment of G-Squared Consortia
Richard Roth’s Media Launches Trust-Driven Performance Media System for Banks, Healthcare, and Legal Services Firms
Northwyn Wellness Group Announces Participation in the 2026 Bloom Burton & Co. Healthcare Investor Conference